Advertisement
U.S. markets close in 3 hours 11 minutes

Bausch Health Companies Inc. (BHC)

NYSE - Nasdaq Real Time Price. Currency in USD
8.09+0.20 (+2.53%)
As of 12:48PM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.90B
Enterprise Value 23.68B
Trailing P/E N/A
Forward P/E 1.90
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.31
Price/Book (mrq)N/A
Enterprise Value/Revenue 2.50
Enterprise Value/EBITDA 8.92

Trading Information

Stock Price History

Beta (5Y Monthly) 0.75
52-Week Change 311.91%
S&P500 52-Week Change 332.33%
52 Week High 311.46
52 Week Low 33.96
50-Day Moving Average 38.40
200-Day Moving Average 37.71

Share Statistics

Avg Vol (3 month) 32.24M
Avg Vol (10 day) 31.36M
Shares Outstanding 5367.8M
Implied Shares Outstanding 6369.53M
Float 8276.57M
% Held by Insiders 111.08%
% Held by Institutions 171.40%
Shares Short (Nov 15, 2024) 49.34M
Short Ratio (Nov 15, 2024) 44.7
Short % of Float (Nov 15, 2024) 42.75%
Short % of Shares Outstanding (Nov 15, 2024) 42.54%
Shares Short (prior month Oct 15, 2024) 412.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 46.52
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Nov 10, 2010
Last Split Factor 22:1
Last Split Date 3Oct 16, 2000

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Sep 30, 2024

Profitability

Profit Margin -1.88%
Operating Margin (ttm)21.67%

Management Effectiveness

Return on Assets (ttm)4.15%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)9.47B
Revenue Per Share (ttm)25.79
Quarterly Revenue Growth (yoy)12.20%
Gross Profit (ttm)N/A
EBITDA 3.07B
Net Income Avi to Common (ttm)-178M
Diluted EPS (ttm)-0.48
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)719M
Total Cash Per Share (mrq)1.96
Total Debt (mrq)21.51B
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.19
Book Value Per Share (mrq)-3.19

Cash Flow Statement

Operating Cash Flow (ttm)1.39B
Levered Free Cash Flow (ttm)1.41B